Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Palonosetron for RINV in primary glioma
NCT00900757Phase 2Completed
- Sponsor
- Duke University
- Start
- Aug 2009
- Primary completion
- Dec 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of palonosetron in Radiation-induced nausea and vomiting (RINV), sponsored by Duke University. Started Aug 2009; status: completed.
02
Drugs
palonosetron
03
Conditions
Radiation-induced nausea and vomiting (RINV)
Beyond the preview
Go deeper on NCT00900757.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00900757.